CONCLUSION
This case summarizes that hyponatremia is an unusual adverse effect of
long-standing use of SSRIs in middle aged adults under treatment for
depressive disorders. Conclusively, this report shows the evidence for
providers to be more cautious in monitoring patients with depressive
disorders when given SSRIs as antidepressant therapy more often when the
treatment is expected to stretch up to 10 years. Red flags such as signs
and symptoms of hyponatremia must immediately be taken notice of
including fits, convulsions or seizures.